1,107 reports of this reaction
5.5% of all LANREOTIDE ACETATE reports
#3 most reported adverse reaction
DEATH is the #3 most commonly reported adverse reaction for LANREOTIDE ACETATE, manufactured by Ipsen Biopharmaceuticals, Inc.. There are 1,107 FDA adverse event reports linking LANREOTIDE ACETATE to DEATH. This represents approximately 5.5% of all 20,256 adverse event reports for this drug.
Patients taking LANREOTIDE ACETATE who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is moderately reported among LANREOTIDE ACETATE users, representing a notable but not dominant share of adverse events.
In addition to death, the following adverse reactions have been reported for LANREOTIDE ACETATE:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 1,107 FDA reports for LANREOTIDE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 5.5% of all adverse event reports for LANREOTIDE ACETATE, making it one of the most commonly reported side effect.
If you experience death while taking LANREOTIDE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.